Recent Advances in Engineering Carriers for siRNA Delivery.

Area of Science:

• Biotechnology
• Nanotechnology
• Molecular Biology

Background:

• RNA interference (RNAi) shows promise for intractable diseases but faces clinical application barriers.
• Extracellular and intracellular barriers hinder effective RNAi therapy delivery.
• The development of siRNA delivery systems is crucial for advancing RNAi therapeutics.

Purpose of the Study:

• To review recent advancements in siRNA carriers for cancer therapy.
• To highlight structural designs of carriers overcoming RNAi delivery hurdles.
• To discuss challenges and future perspectives for clinical RNAi modality.

Main Methods:

• Summarization of recent advances in siRNA carriers (lipids, polymers, polymer-modified inorganic particles).
• Presentation of representative examples of carrier structural designs.
• Discussion of existing challenges and future outlook for RNAi clinical development.

Main Results:

• Lipid-based carriers, like Patisiran, represent a milestone in RNAi therapeutics.
• Various siRNA carriers, including polymers and inorganic particles, are being developed for cancer therapy.
• Structural design of carriers is key to overcoming delivery hurdles.

Conclusions:

• Advances in siRNA carriers are essential for overcoming RNAi delivery barriers.
• Continued research into novel carrier systems will promote clinical applications of RNAi.
• The development of effective siRNA delivery systems holds significant potential for future cancer therapies.